APA (7th ed.) Citation

MC, G., R, B., L, L., L, T., MC, T., FC, B., . . . RC, B. (2026). Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stage triple-negative breast cancer: Real-world insights from neo-real/GBECAM-0123. NPJ breast cancer, 12(1), . https://doi.org/10.1038/s41523-026-00919-y

Chicago Style (17th ed.) Citation

MC, Gouveia, et al. "Neoadjuvant Pembrolizumab Plus Chemotherapy in Older Patients with Early-stage Triple-negative Breast Cancer: Real-world Insights from Neo-real/GBECAM-0123." NPJ Breast Cancer 12, no. 1 (2026). https://doi.org/10.1038/s41523-026-00919-y.

MLA (9th ed.) Citation

MC, Gouveia, et al. "Neoadjuvant Pembrolizumab Plus Chemotherapy in Older Patients with Early-stage Triple-negative Breast Cancer: Real-world Insights from Neo-real/GBECAM-0123." NPJ Breast Cancer, vol. 12, no. 1, 2026, https://doi.org/10.1038/s41523-026-00919-y.